buccalin: colocalized with the small cardioactive peptides to neuron B15; bioactive at the ARC neuromuscular junction [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 11105112 |
| MeSH ID | M0163573 |
| Synonym |
|---|
| buccalin |
| NCGC00167205-01 |
| 116844-51-0 |
| 116786-35-7 |
| l-leucinamide, glycyl-l-methionyl-l-alpha-aspartyl-l-seryl-l-leucyl-l-alanyl-l-phenylalanyl-l-serylglycylglycyl- |
| (3s)-3-[(2s)-2-(2-aminoacetamido)-4-(methylsulfanyl)butanamido]-3-{[(1s)-1-{[(1s)-1-{[(1s)-1-{[(1s)-1-{[(1s)-1-({[({[(1s)-1-carbamoyl-3-methylbutyl]carbamoyl}methyl)carbamoyl]methyl}carbamoyl)-2-hydroxyethyl]carbamoyl}-2-phenylethyl]carbamoyl}ethyl]carbam |
| Excerpt | Relevance | Reference |
|---|---|---|
| " The seven active peptides showed similar dose-response curves." | ( Functional redundancy of FMRFamide-related peptides at the Drosophila larval neuromuscular junction. Hewes, RS; Saitoe, M; Snowdeal, EC; Taghert, PH, 1998) | 0.3 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (5.00) | 18.7374 |
| 1990's | 15 (75.00) | 18.2507 |
| 2000's | 3 (15.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.
| This Compound (57.46) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (4.76%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 20 (95.24%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||